CV vs MS · rev $3.5M vs P/E 20, $344.27B cap
CapsoVision, Inc. Common Stock (CV) versus Morgan Stanley (MS) — a side-by-side from cached financials, not a winner call.
CapsoVision, Inc. Common Stock (CV) is a medical devices company listed on US.
Morgan Stanley (MS) is a capital markets company listed on US. It is led by Ted Pick.
Latest reported CV revenue for 2025-09-30 was $3.5M. Net income was -$7.9M. Revenue was up 6.7% from 2025-06-30 to 2025-09-30. CV currently screens at market cap $359.2M.
MS does not have a complete income-statement cache yet.
CV currently screens at market cap $359.2M. MS currently screens at market cap $344.27B and trailing P/E 19.8.
Not investment advice. Open the CV and MS stock pages for the full models.
Not investment advice.